Receipt of recommended complications and comorbidities screening in youth and young adults with type 1 diabetes: Associations with metabolic status and satisfaction with care.


Journal

Pediatric diabetes
ISSN: 1399-5448
Titre abrégé: Pediatr Diabetes
Pays: Denmark
ID NLM: 100939345

Informations de publication

Date de publication:
03 2020
Historique:
received: 17 08 2019
revised: 26 10 2019
accepted: 01 11 2019
pubmed: 5 12 2019
medline: 17 2 2021
entrez: 5 12 2019
Statut: ppublish

Résumé

This study sought to: (a) assess the prevalence of diabetes complications and comorbidities screening as recommended by the American Diabetes Association (ADA) for youth and young adults (YYAs) with type 1 diabetes (T1D), (b) examine the association of previously measured metabolic status related to diabetes complications with receipt of recommended clinical screening, and (c) examine the association of satisfaction with diabetes care with receipt of recommended clinical screening. The study included 2172 SEARCH for Diabetes in Youth participants with T1D (>10 years old, diabetes duration >5 years). Mean participant age was 17.7 ± 4.3 years with a diabetes duration of 8.1 ± 1.9 years. Linear and multinomial regression models were used to evaluate associations. Sixty percent of participants reported having three or more hemoglobin A1c (HbA1c) measurements in the past year. In terms of diabetes complications screening, 93% reported having blood pressure measured, 81% having an eye examination, 71% having lipid levels checked, 64% having a foot exam, and 63% completing albuminuria screening in accordance with ADA recommendations. Youth known to have worse glycemic control in the past had higher odds of not meeting HbA1c screening criteria (OR 1.11, 95% CI = 1.05, 1.17); however, after adjusting for race/ethnicity, this was no longer statistically significant. Greater satisfaction with diabetes care was associated with increased odds of meeting screening criteria for most of the ADA-recommended measures. Efforts should be made to improve diabetes complications screening efforts for YYAs with T1D, particularly for those at higher risk for diabetes complications.

Identifiants

pubmed: 31797506
doi: 10.1111/pedi.12948
pmc: PMC7597528
mid: NIHMS1622127
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

349-357

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK057516
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP006134
Pays : United States
Organisme : CDC HHS
ID : U48/CCU419249
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002714
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000244
Pays : United States
Organisme : CDC HHS
ID : U18DP002714
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000062
Pays : United States
Organisme : ACL HHS
ID : U18DP006134
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001425
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000423
Pays : United States
Organisme : ACL HHS
ID : U18DP006139
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK108173
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000247
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP003256
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002710
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR00423
Pays : United States
Organisme : NIH HHS
ID : P30 DK57516
Pays : United States
Organisme : CDC HHS
ID : U58/CCU019235‐4
Pays : United States
Organisme : ACL HHS
ID : U18DP006138
Pays : United States
Organisme : CDC HHS
ID : U48/CCU519239
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000154
Pays : United States
Organisme : NIH HHS
ID : 1UC4DK108173
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000248
Pays : United States
Organisme : CDC HHS
ID : 00097
Pays : United States
Organisme : CDC HHS
ID : 1U18DP002709
Pays : United States
Organisme : CDC HHS
ID : U18DP002710-01
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002709
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP006133
Pays : United States
Organisme : ACL HHS
ID : U18DP006131
Pays : United States
Organisme : CDC HHS
ID : DP-10-001
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP006139
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000077
Pays : United States
Organisme : CDC HHS
ID : DP-05-069
Pays : United States
Organisme : ACL HHS
ID : U18DP006136
Pays : United States
Organisme : CDC HHS
ID : U18DP000247-06A1
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000250
Pays : United States
Organisme : CDC HHS
ID : U48/CCU919219
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK119465
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000246
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001450
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000254
Pays : United States
Organisme : ACL HHS
ID : U18DP006133
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002708
Pays : United States
Organisme : CDC HHS
ID : U48/CCU819241‐3
Pays : United States
Organisme : HSRD VA
ID : HIR 10-001
Pays : United States
Organisme : CDC HHS
ID : U18DP002708
Pays : United States

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

N Engl J Med. 1993 Sep 30;329(14):977-86
pubmed: 8366922
Pediatrics. 2011 Sep;128(3):531-8
pubmed: 21859914
Diabetes Care. 2017 Jan;40(Suppl 1):S6-S10
pubmed: 27979888
Diabetes Care. 2015 Jun;38(6):971-8
pubmed: 25998289
Diabet Med. 2012 Jul;29(7):937-44
pubmed: 22417277
Diabetes Care. 2014 Feb;37(2):402-8
pubmed: 24041677
BMJ Open. 2013 Jan 03;3(1):
pubmed: 23293244
Health Psychol. 2017 Mar;36(3):206-214
pubmed: 27736152
BMJ. 1999 Feb 20;318(7182):527-30
pubmed: 10024268
Diabetes Care. 2013 Dec;36(12):3903-8
pubmed: 24144652
BMC Health Serv Res. 2015 Dec 15;15:553
pubmed: 26666413
Diabetes Care. 2013 Jul;36(7):2035-7
pubmed: 23340893
Med Care. 2006 Feb;44(2):132-40
pubmed: 16434912
J Pediatr Health Care. 2016 Jul-Aug;30(4):381-9
pubmed: 26559135
Diabetes Care. 2014 Dec;37(12):3336-44
pubmed: 25414389
N Engl J Med. 2017 Apr 13;376(15):1419-1429
pubmed: 28402773
Diabetes Care. 2005 Jan;28(1):186-212
pubmed: 15616254
Ann Epidemiol. 1997 Jul;7(5):334-42
pubmed: 9250628
Inquiry. 1988 Spring;25(1):25-36
pubmed: 2966123
Am J Manag Care. 2011 Jan;17(1):41-8
pubmed: 21348567
Diabetes Care. 2013 Apr;36(4):1033-46
pubmed: 23468086
Diabetes Care. 2011 Jul;34(7):1651-9
pubmed: 21709298
Med Care. 2004 Feb;42(2):110-5
pubmed: 14734947
Curr Diab Rep. 2015 Dec;15(12):112
pubmed: 26458383
Ophthalmology. 1986 Sep;93(9):1183-7
pubmed: 3101021
JAMA Oncol. 2017 Aug 1;3(8):1035-1042
pubmed: 28208186
JAMA. 2017 Feb 28;317(8):825-835
pubmed: 28245334
J Gen Intern Med. 2008 Oct;23(10):1685-7
pubmed: 18661189
Pediatr Diabetes. 2018 Oct;19 Suppl 27:84-104
pubmed: 30144259
Lancet. 2012 Jun 16;379(9833):2252-61
pubmed: 22683130
Can J Diabetes. 2017 Feb;41(1):17-25
pubmed: 27789111
J Pediatr. 1994 Aug;125(2):177-88
pubmed: 8040759

Auteurs

Faisal S Malik (FS)

Department of Pediatrics, University of Washington, Seattle, Washington.

Jeanette M Stafford (JM)

Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Beth A Reboussin (BA)

Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Georgeanna J Klingensmith (GJ)

Barbara Davis Center, University of Colorado Denver School of Medicine, Aurora, Colorado.

Dana Dabelea (D)

Department of Epidemiology, Colorado School of Public Health, Aurora, Colorado.

Jean M Lawrence (JM)

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.

Elizabeth Mayer-Davis (E)

Department of Nutrition and Medicine, University of North Carolina, Chapel Hill, North Carolina.

Sharon Saydah (S)

Division of Diabetes Translation, Centers for Disease Control and Prevention, Georgia.

Sarah Corathers (S)

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Catherine Pihoker (C)

Department of Pediatrics, University of Washington, Seattle, Washington.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH